About this Event
The Inflation Reduction Act (IRA)’s new approach to prescription drug pricing marks a significant shift in how Medicare pays for medications, with potential consequences for patient access nationwide. To explore these implications, the Institute is pleased to welcome Dr. Tomas J. Philipson, former Acting Chairman of the Council of Economic Advisers and University of Chicago professor, as our 2025 Hewitt Healthcare Lecturer.
In his lecture, Dr. Philipson will analyze how insurance companies and Ph*rm*cy benefit managers are responding to these pricing reforms, and what their decisions could mean for both current Medic*tion access and future drug innovation.
Attendees will also receive an exclusive demonstration of Pioneer’s innovative new webtool that tracks the implementation and effects of the IRA on Medicare Part D coverage.
Named for Pioneer’s former Chairman, Charles “Colby” Hewitt, Jr., the annual Hewitt Healthcare Lecture brings together the nation’s top healthcare and life sciences experts to discuss the most pressing issues facing our country’s health sector.
Don't miss your chance to attend this important discussion the critical issues facing the American healthcare system!
For questions about reserving a seat or sponsoring the 2025 Hewitt Healthcare Lecture, please contact John Guerra at .
Meet the Speaker:
is the Daniel Levin Professor of Public Policy Studies Emeritus at the University of Chicago Harris School of Public Policy. He directs the Becker Friedman Institute's Program on Foundational Research in Health Care Markets and Policies and is affiliated with the Economics Department and Law School. His research focuses on health economics.
Born and raised in Sweden, Philipson earned his undergraduate degree in mathematics from Uppsala University and his MA and PhD in economics from the Wharton School at the University of Pennsylvania.
Philipson has extensive government experience, serving as senior economic advisor at both the FDA and the Centers for Medicare and Medicaid Services during the second Bush Administration. He advised Senator John McCain's presidential campaign and served on the Key Indicator Commission created by the Affordable Care Act. He also contributed to the 21st Century Cures legislation and Vice President Biden's Cancer Moon Shot Initiative.
His academic achievements include twice winning the Kenneth Arrow Award, the highest honor in health economics. He has received grants from prominent organizations including the NIH, NSF, and the Royal Swedish Academy of Sciences. Philipson's research appears in leading economics journals and he is a founding editor of Forums for Health Economics & Policy.
Beyond academia, Philipson consults for Fortune 100 companies and government organizations worldwide. He co-founded Precision Heath Economics LLC in 2007 and regularly contributes op-eds to Forbes. He frequently appears in major media outlets and speaks at healthcare conferences globally.
Event Venue & Nearby Stays
WilmerHale, 60 State Street, Boston, United States
USD 50.00 to USD 10000.00
